M. Menéndez

发表

Factor V Leiden (R506Q) and risk of venous thromboembolism: a case‐control study based on the Spanish population

V. Álvarez, E. Coto, C. López-Larrea, 1997, Clinical genetics.

The screening of the 3′UTR sequence of LRRK2 identified an association between the rs66737902 polymorphism and Parkinson’s disease

V. Álvarez, E. Coto, I. Mata, 2014, Journal of Human Genetics.

Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165/rs11931074 polymorphisms

V. Álvarez, E. Coto, I. Mata, 2014, Neuroscience Letters.

SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V

V. Álvarez, E. Coto, J. Infante, 2013, Clinical genetics.

Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer.

V. Álvarez, E. Coto, María Verónica González, 1998, Journal of clinical pathology.

A new de novo Notch3 mutation causing CADASIL

V. Álvarez, M. García-Castro, R. Navarro, 2006, European journal of neurology.

1.P.229 Polymorphisms of the platelet receptor IIIa and lipid levels in early coronary disease

E. Coto, A. Batalla, S. Hevia, 1997 .

Late-onset Alzheimer's disease is associated with mitochondrial DNA 7028C/haplogroup H and D310 poly-C tract heteroplasmy

V. Álvarez, E. Coto, C. Martínez, 2011, neurogenetics.

PCR-based study of the presence of Y-chromosome sequences in patients with Ullrich-Turner syndrome.

E. Coto, C. López-Larrea, A. Plasencia, 1995, American journal of medical genetics.

Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma.

V. Álvarez, M. Fresno, María Verónica González, 1997, Journal of clinical pathology.

Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and neck squamous cell carcinoma.

E. Coto, María Verónica González, C. López-Larrea, 1997, Journal of clinical pathology.

Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.

E. Coto, María Verónica González, C. López-Larrea, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Profile of microRNAs in the plasma of Parkinson’s disease patients and healthy controls

V. Álvarez, E. Coto, L. Cardo, 2013, Journal of Neurology.

Mutational Screening of PARKIN Identified a 3′ UTR Variant (rs62637702) Associated with Parkinson’s Disease

V. Álvarez, E. Coto, P. Pástor, 2013, Journal of Molecular Neuroscience.

Analysis of the Micro‐RNA‐133 and PITX3 genes in Parkinson's disease

Marta Blázquez, Pau Pastor, V. Álvarez, 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

MiRNA Profile in the Substantia Nigra of Parkinson’s Disease and Healthy Subjects

V. Álvarez, E. Coto, L. Cardo, 2014, Journal of Molecular Neuroscience.

A Search for SNCA 3′ UTR Variants Identified SNP rs356165 as a Determinant of Disease Risk and Onset Age in Parkinson’s Disease

V. Álvarez, E. Coto, P. Pástor, 2011, Journal of Molecular Neuroscience.

Myocyte enhancing factor-2A in Alzheimer's disease: Genetic analysis and association with MEF2A-polymorphisms

V. Álvarez, E. Coto, M. García-Castro, 2007, Neuroscience Letters.

Sampling Defective Pathways in Parkinson Disease

Enrique J. deAndrés-Galiana, Ana Cernea, Juan Luis Fernández-Martínez, 2019, Journal of Medical Informatics and Decision Making.

Amyloid Precursor Protein Gene (APP) Variation in Late-Onset Alzheimer’s Disease

V. Álvarez, E. Coto, C. Martínez, 2011, Journal of Molecular Neuroscience.

Lack of association between protocadherin 11-X/Y (PCDH11X and PCDH11Y) polymorphisms and late onset Alzheimer's disease

V. Álvarez, E. Coto, C. Martínez, 2011, Brain Research.